Angela Nocera

Title: Angela Nocera: Innovator in Chronic Rhinosinusitis Research

Introduction

Angela Nocera is a prominent inventor based in Boston, MA, who has made significant contributions to the field of medical research. She is particularly known for her work on chronic rhinosinusitis, a condition that affects many individuals worldwide. Her innovative approach has led to the development of a unique biomarker that can aid in the diagnosis and treatment of this condition.

Latest Patents

Angela Nocera holds a patent titled "Secreted P-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis - Methods for identifying and optionally treating subjects, e.g., subjects who have Chronic Rhinosinusitis (CRS), based on the detection of elevated levels of soluble P-glycoprotein in nasal secretions." This patent outlines methods for identifying and treating subjects with CRS by detecting elevated levels of soluble P-glycoprotein in their nasal secretions. The treatment methods can include the administration of a therapeutically effective amount of a P-glycoprotein inhibitor. She has 1 patent to her name.

Career Highlights

Angela Nocera is affiliated with the Massachusetts Eye and Ear Infirmary, where she conducts her research and develops her innovative methods. Her work has garnered attention for its potential to improve the lives of those suffering from chronic rhinosinusitis.

Collaborations

Angela collaborates with Benjamin S. Bleier, a fellow researcher in the field. Their partnership has been instrumental in advancing the understanding and treatment of chronic rhinosinusitis.

Conclusion

Angela Nocera's contributions to the field of chronic rhinosinusitis research highlight her innovative spirit and dedication to improving patient outcomes. Her work continues to pave the way for new diagnostic and treatment methods in this important area of healthcare.